Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.

Date publication

février 2021

Journal

Trials

Auteurs

Membres identifiés du Cancéropôle Est :
Dr CHAMARAUX-TRAN Thiên-Nga

Tous les auteurs :
Muller M, Lefebvre F, Harlay ML, Glady L, Becker G, Muller C, Aberkane O, Tawk M, Julians M, Romoli A, Hecketsweiler S, Schneider F, Pottecher J, Chamaraux-Tran TN

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/33573681

Résumé

The main objective of this study is to evaluate the effect of intravenous lidocaine on gas exchange and inflammation in acute respiratory distress syndrome due or not to Covid-19 pneumonia.

Mots clés

COVID-19, Randomised controlled trial, lidocaine, local anaesthetics, molecular mechanisms of pharmacological action, protocol, severe acute respiratory syndrome

Référence

Trials. 2021 Feb 11;22(1):131